BioSpace News Archive

IAMA Therapeutics Partners with the Italian Institute of Technology to Embark on Landmark Research on Neuroscience Drug Discovery

IAMA Therapeutics announced a strategic collaboration with the IIT-Istituto Italiano di Tecnologia - where they will design and profile new classes of compounds targeting cation cotransporters in the CNS area.

March 29, 2022
·
3 min read
Business

Pyxis Oncology Provides Corporate and Financial Update

Pyxis Oncology, Inc., a multi-asset multi-modality company focused on developing next-generation therapeutics for difficult to treat cancers, provided a corporate and financial update and reported financial results for the full year ended December 31, 2021.

March 29, 2022
·
9 min read
Business

I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2021

I-Mab announced financial results for the 12 months ended December 31, 2021, and provided key business updates.

March 29, 2022
·
53 min read
Anesthesia Conduction Kits Market: Rise in the Number of Surgeries to Drive the Market

Anesthesia conduction is a methodology through which local anesthetic solution is injected to the site of the body where the nerves are inhibited to transfer any pain receptors signals during surgery or other treatment procedures.

March 29, 2022
·
5 min read
Cardiac Stimulators Market: Rise in prevalence of cardiac rhythm disorders to drive the market

Cardiac stimulators or pacemakers are devices that deliver electrical impulses through electrodes to increase heart rate to normal levels. These devices normalize the heart rate in patients suffering from arrhythmias, especially bradycardia.

March 29, 2022
·
4 min read
Somatostatinoma Treatment Market: Combination Drug Therapy to Witness High Demand

Based on data published in the National Center for Biotechnology Information, an estimated incidence rate of Somatostatinoma is of 1/40,000,000 globally.

March 29, 2022
·
5 min read
Policy

Santhera and ReveraGen Start Rolling NDA Submission to the FDA for Vamorolone for the Treatment of Duchenne Muscular Dystrophy

Pratteln, Switzerland, March 29, 2022 – Santhera Pharmaceuticals and ReveraGen BioPharma, Inc announce the initiation of a rolling new drug application submission to the U.S. Food and Drug Administration for vamorolone for the treatment of Duchenne muscular dystrophy.

March 29, 2022
·
7 min read
Business

Press Release: Sanofi and IGM Biosciences Announce Collaboration Agreement for Oncology, Immunology and Inflammation Targets

Sanofi and IGM Biosciences, Inc. announced the signing of an exclusive worldwide collaboration agreement to create, develop, manufacture, and commercialize IgM antibody agonists against three oncology targets and three immunology/inflammation targets.

March 29, 2022
·
11 min read
Valbiotis Announces the Positive Results of Its Clinical Study on the Bioavailability and Mode of Action of TOTUM•070, Against Hypercholesterolemia

Valbiotis, a Research and Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, announces the positive results of its clinical study on the bioavailability and mode of action of TOTUM•070 against hypercholesterolemia.

March 29, 2022
·
7 min read
Business

Sense Appoints Michael Jones as Chief Financial Officer

Global molecular diagnostics innovator, Sense Biodetection, announced the appointment of Michael Jones as chief financial officer.

March 29, 2022
·
2 min read